DAIC

FEBRUARY 2, 2024

milla1cf Fri, 02/02/2024 - 17:18 February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 with CardioLab EP Recording system, to help clinicians in the diagnosis and treatment of cardiac arrhythmias. million people in the United States by 2050 and 17.9

Electrophysiology 101

Electrophysiology Innovation AFIB Atrial Fibrillation 101

DAIC

JULY 16, 2024

mtaschetta-millane Tue, 07/16/2024 - 09:47 July 16, 2024 — Ultrahuman, a pioneer in wearable technology , launches PowerPlugs, a platform for individual apps and plugins built on top of Ultrahuman’s health and wellness data stack. AFib is the most common type of irregular heart rhythm or arrhythmia.

AFIB 103

AFIB Technology Heart Rhythm Arrhythmia 103

HeartRhythm

AUGUST 27, 2024

The same holds true for the adoption of artificial intelligence (AI) by clinical cardiac electrophysiology.

Electrophysiology 40

Electrophysiology Technology Innovation Arrhythmia 40

DAIC

JULY 15, 2024

Health systems leveraging Guidehealth can seamlessly integrate Story Health’s program to support at-risk patients with heart conditions like heart failure, hypertension, and arrhythmia, providing better care while also reducing the total cost of care, according to a written statement detailing the deal.

Technology 105

Technology Innovation Nursing Heart Failure 105

HeartRhythm

MARCH 26, 2024

Dr Wilkoff was an innovator in the field of cardiac implantable electronic devices (CIEDs). Wilkoff, MD, one of the most impactful and pioneering members of the Heart Rhythm Society (HRS).

Heart Rhythm 45

Heart Rhythm Electrophysiology Innovation Technology 45

DAIC

FEBRUARY 27, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi , announced the commencement of patient cases with the investigational Laminar Left Atrial Appendage Elimination (LAAX) System as part of its pivotal investigational device exemption (IDE) study. Jennifer Currin, Ph.D., The acquisition of Laminar, Inc.

Atrial Fibrillation 105

Atrial Fibrillation Innovation AFIB Pharmacology 105

GEMMS

MAY 22, 2024

Advancements in medical technology have revolutionized the diagnosis and treatment of heart diseases, which pose critical chronic conditions that, if left unattended, can have fatal consequences. Startups are developing image analytics solutions using deep learning technologies to improve patient outcomes.

Heart Disease 52

Heart Disease Blood Pressure Technology Innovation 52

Wellnest

JUNE 19, 2023

By harnessing the power of the latest technology, healthcare providers can enhance diagnostics, treatment planning, and patient care. The latest technology utilizes the existing data of an Artificial Neural network (ANN). Novel technology is also proving to be better than traditional conventional ECG machines. For instance: 1.

Cardiac Arrest 52

Cardiac Arrest Technology Coronary Artery Disease Innovation 52

Dr. S. Venkatesan MD

JUNE 16, 2024

Any deviation or trespassing results in arrhythmia. We must thank the technological innovators in the electro-anatomical mapping system, who are continuously upgrading and providing the best to us. This is what DC shocks do for temporary reversion to sinus rhythm ) How to localize the diastolic pathways ?

Ablation 52

Ablation Physiology Technology Bicuspid/Mitral 52

DAIC

MARCH 5, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech , today announced European CE mark approval of the VARIPULSE Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation ( AF ) using pulsed field ablation (PFA). [ii]

Ablation 59

Ablation Atrial Fibrillation Atrial Flutter Pulmonary 59

DAIC

APRIL 9, 2024

It is also published in Heart Rhythm , the official journal of the HRS, Journal of Arrhythmia , the official journal of the APHRS, and Journal of Interventional Cardiac Electrophysiology , the official journal of the LAHRS. Antiarrhythmic drugs are advised for some patients to prevent arrhythmia recurrences early after the procedure.

Atrial Fibrillation 105

Atrial Fibrillation Ablation Heart Rhythm Blood Clot 105

CineECG

MAY 22, 2023

Over the past 3 days cardiologists from all over the world met in New Orleans to learn and discuss the developments in technology and patient care. As ECG Excellence we are proud our CineECG technology was part of this innovation festival. HRS 2023 is a wrap!

Technology 52

Technology Atrial Fibrillation Anatomy Innovation 52

DAIC

DECEMBER 19, 2023

OSA is commonly seen in patients with arrhythmias like atrial fibrillation (AFib) and due to the variable unpredictable nature of sleep apnea symptoms, it is often untreated, leading to adverse outcomes. Peerbridge Health continues to innovate by compounding clinical utility in one simple device," said Andrea Natale, M.D.,

Heart Failure 52

Heart Failure Heart Disease Innovation Quality of Life 52

Vector Remote

APRIL 14, 2023

History & Future of Cardiac Remote Patient Monitoring Healthcare reforms fueled by government legislation and recent technological innovations have propelled cardiac remote patient monitoring to the forefront in the early 2020s, but the history of cardiac remote patient monitoring dates to more than half a century ago.

Pacemaker 52

Pacemaker Technology COVID-19 Blood Pressure 52

DAIC

MARCH 1, 2024

We have ways of preventing sudden cardiac arrest through technologies like a defibrillator, but the challenge is knowing who is most likely to benefit from this intervention,” said Lauri Holmstrom, MD, PhD, a visiting postdoctoral scientist at Cedars-Sinai and first author of both studies.

Cardiac Arrest 111

Cardiac Arrest Electrocardiogram Defibrillator Electrophysiology 111

MIBHS

SEPTEMBER 15, 2023

Among these innovations, minimally invasive cardiac surgery stands out as a game-changer, offering numerous benefits over traditional open-heart surgery. Due to the prevalence of cardiovascular disease, there are continuous advancements in cardiac surgery techniques. This reduced risk enhances the overall safety profile of these procedures.

Open-Heart Surgery 52

Open-Heart Surgery Coronary Artery Bypass Graft Cardiovascular Disease Innovation 52

DAIC

FEBRUARY 2, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi , revealed findings from a company-funded study of real-world data. AFib is the most common type of cardiac arrhythmia and affects more than 6 million people in the United States and nearly 38 million people worldwide.2,3

Ablation 105

Ablation Atrial Fibrillation AFIB Heart Rhythm 105

ADN Center of Excellence

SEPTEMBER 28, 2023

Their expertise covers a wide range of cardiovascular conditions, including coronary artery disease, heart failure, arrhythmias, and congenital heart defects. Advancements in Cardiology Cardiology is a dynamic field, with ongoing research and technological advancements that continue to transform patient care.

COVID-19 52

COVID-19 Heart Disease Education Coronary Artery Disease 52

DAIC

JUNE 25, 2024

Food and Drug Administration ( FDA ) clearance and commercial launch of KAI 12L AI technology and the Kardia 12L ECG System. The Kardia 12L ECG System, featuring a game-changing patented technology, is the world’s first AI-powered handheld 12-lead electrocardiogram ( ECG ) system with a unique single-cable design.

Technology 116

Technology Heart Attack Heart attacks Innovation 116

DAIC

MAY 21, 2024

Stereotaxis will present an innovative proposal leveraging advanced robotic technology and telerobotic presence to sustainably offer high-quality cardiac ablation therapy in underserved regions of Africa. When left untreated, arrhythmias may significantly increase the risk of stroke, heart failure, and sudden cardiac arrest.

Heart Rhythm 52

Heart Rhythm Innovation Electrophysiology Technology 52

Cardiometabolic Health Congress

AUGUST 8, 2024

We need a comprehensive and innovative approach to cardiorenal metabolic management and risk reduction to address this challenge. These interconnected diseases pose a significant global health threat, with cardiovascular diseases alone accounting for one-third of all deaths worldwide , according to the World Health Organization.

Education 59

Education Kidney Disease Diabetes Cardiovascular Disease 59

DAIC

JULY 24, 2024

Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. Volta Medical’s AI solution is designed to assist electrophysiologists in real-time assessment of dispersed electrograms (EGMs).

Atrial Fibrillation 105

Atrial Fibrillation AFIB Ablation Technology 105

Cardiomatics

AUGUST 4, 2022

Technology provides us with more and more possibilities in many areas of life, including medicine. It is no longer just a future dream, but a new reality for clinicians and patients who can already benefit from new technologies. The available technology allows us to monitor patients 24/7, both in a hospital and at home.

Cardiovascular Disease 52

Cardiovascular Disease Technology COVID-19 Cerebrovascular Disease 52

Dr. S. Venkatesan MD

FEBRUARY 20, 2024

In myocardial pathology, the genesis and sustainability of ventricular arrhythmia are intricately related to the degree of LV dysfunction of any cause. Still, Mirowski”s electrical kid survived the test of time and evolved with great technological innovations from companies like Medtronic, Guidant, Abbot etc.

Heart Failure 52

Heart Failure Defibrillator Sudden Cardiac Death Cardiomyopathy 52

DAIC

MAY 18, 2024

Atrial fibrillation is the most common type of arrhythmia, and by 2050, up to 16 million Americans are projected to have AF 1. Recent technological advancements, such as catheter design and energy delivery, can pave the way for the wider adoption of PFA in clinical practice to improve patient outcomes.

Heart Rhythm 105

Heart Rhythm Atrial Fibrillation Ablation Quality of Life 105

DAIC

DECEMBER 26, 2023

a company primarily focused on leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial fibrillation, announced the completion of the first five procedures in its first-in-human feasibility study with its novel CellFX nsPFA cardiac catheter.

Ablation 59

Ablation Atrial Fibrillation Technology Hospital 59